761440-64-6

Basic information

• Product Name: 1-(3-Methoxy-4-nitrophenyl)piperidin-4-one
• Synonyms: 1-(3-Methoxy-4-nitrophenyl)piperidin-4-one
• CAS NO: 761440-64-6
• Molecular Formula: C₁₂H₁₄N₂O₄
• Molecular Weight: 250.25056
• EINECS: 1592732-453-0
• Mol File: 761440-64-6.mol
• Article Data: 14

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-(3-Methoxy-4-nitrophenyl)piperidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-Methoxy-4-nitrophenyl)piperidin-4-one(761440-64-6)
• EPA Substance Registry System: 1-(3-Methoxy-4-nitrophenyl)piperidin-4-one(761440-64-6)

Safety Data

• Hazardous Substances Data: 761440-64-6(Hazardous Substances Data)

Usage

General Description

1-(3-methoxy-4-nitrophenyl)piperidin-4-one is a chemical compound with the molecular formula C13H15N3O4. It is a piperidin-4-one derivative with a 3-methoxy-4-nitrophenyl group attached to the piperidine ring. 1-(3-methoxy-4-nitrophenyl)piperidin-4-one is commonly used as a building block in the synthesis of pharmaceuticals and other organic compounds. It has shown potential as an intermediate in the development of new drugs for various therapeutic applications. Its unique structure makes it a valuable component in medicinal chemistry and organic synthesis. However, it should be handled with care and caution due to potential hazards associated with its handling and use.

Upstream product

• 446-36-6 5-fluoro-2-nitrophenol 
• 448-19-1 4-fluoro-2-methoxy-1-nitrobenzene 
• 40064-34-4 4-piperidone monohydrochloride monohydrate 
• 5382-16-1 4-HYDROXYPIPERIDINE 
• 761440-22-6 1-(3-methoxy-4-nitrophenyl)piperidin-4-ol 
• 41979-39-9 4-piperidone hydrochloride 

Downstream Products

• 1089279-90-2 1-(3-methoxy-4-nitrophenyl)-N,N-dimethylpiperidine-4-amine 
• 1089281-10-6 4-{1-[3-(methyloxy)-4-nitrophenyl]-4-piperidinyl}-2-piperazinone 
• 1089279-61-7 4-(1-(3-methoxy-4-nitrophenyl)piperidin-4-yl)piperazine 
• 1097917-15-1 N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)-piperidin-1-yl]phenyl}-N′-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine 
• 1089279-91-3 1-(4-amino-3-methoxyphenyl)-N,N-dimethylpiperidine-4-amine 
• 1356962-95-2 N-cyclopropyl-1-(3-methoxy-4-nitrophenyl)piperidin-4-amine 
• 1246532-92-2 1-[1-(3-methoxy-4-nitro-phenyl)-4-piperidyl]piperidin-3-ol 
• 761440-42-0 1-acetyl-4-{1-[3-(methyloxy)-4-nitrophenyl]-4-piperidinyl}piperazine 
• 761440-35-1 4-(1-(3-methoxy-4-nitrophenyl)piperidin-4-yl)morpholine 
• 761440-23-7 1-(3-methoxy-4-nitro-phenyl)-4-pyrrolidin-1-yl-piperidine 
• 1089279-66-2 tert-butyl 4-(1-(3-methoxy-4-nitrophenyl)piperidin-4-yl)piperazine-1-carboxylate 
• 761440-65-7 1-(1-(3-methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine 

Relevant articles and documents

Synthesis method of Brigatinib intermediate

The invention discloses a synthesis method of a Brigatinib intermediate. The Brigatinib intermediate is 2-methoxy-4-(4-(4-methyl piperazine-1-yl) piperidine-1-yl) aniline (I). The synthesis method comprises the following steps: taking 5-fluoro-2-nitroanis

Preparation method and crystal form of deuterated diphenyl amino pyrimidine compound

The present invention discloses a preparation method and a crystal form of a compound shown in the formula (A) and also discloses a pharmaceutical composition comprising the crystal form of the compound shown in the formula (A) and a method for treating A

2,4-dibasic miazines compound

The invention belongs to the field of medical chemistry, relates to a 2,4-dibasic miazines compound and specifically relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof, a drug compound thereof and an application thereof in treating EGFR or/and ALK mediated diseases.